Academic Conference Presentation on the Results of Phase 1 Clinical Study in Europe on a Novel Universal Influenza Vaccine Candidate Formulated with Sumitomo Pharma’s Proprietary TLR7 Adjuvant (DSP-0546)

Announce the publication of a comprehensive Adjuvant Database to facilitate preclinical evaluation of vaccines and immunotherapeutics

Interim Analysis of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate Formulated with Sumitomo Pharma’s Proprietary TLR7 Adjuvant (DSP-0546)

Seminar and Symposium will be held at Tokyo International Conference on African Development (TICAD9)!

The Logo and Abbreviation will be changed for the 10th Anniversary from April!

NIHN Fellowship Program for Asian Researchers 2025-2026 Registration is now open

CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy | National Institutes of Biomedical Innovation, Health and Nutrition

A redesigned website for the WHO Collaborating Centre has been launched.

Start of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate

The report of the 11th Asian Network Symposium on Nutrition (January 24, 2024) was uploaded.

A list of previous fellows for the NIBIOHN Fellowship Program for Asian Researchers has been updated.